IRIS UniCatt

Nero, Camilla
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.707
AS - Asia 1.624
EU - Europa 1.406
SA - Sud America 409
AF - Africa 43
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.197
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.622
SG - Singapore 768
IT - Italia 395
CN - Cina 370
BR - Brasile 334
SE - Svezia 237
DE - Germania 222
VN - Vietnam 102
IN - India 97
GB - Regno Unito 96
FR - Francia 82
IE - Irlanda 82
FI - Finlandia 69
HK - Hong Kong 66
ID - Indonesia 62
UA - Ucraina 54
RU - Federazione Russa 38
NL - Olanda 36
CA - Canada 35
KR - Corea 29
MX - Messico 26
AR - Argentina 25
BD - Bangladesh 25
AT - Austria 18
PL - Polonia 18
JP - Giappone 16
BE - Belgio 15
ES - Italia 14
EC - Ecuador 13
TR - Turchia 13
ZA - Sudafrica 13
IQ - Iraq 11
IR - Iran 11
MA - Marocco 9
PH - Filippine 8
CO - Colombia 7
VE - Venezuela 7
CI - Costa d'Avorio 6
CZ - Repubblica Ceca 6
IL - Israele 6
PK - Pakistan 6
PY - Paraguay 6
CL - Cile 5
SA - Arabia Saudita 5
HN - Honduras 4
JO - Giordania 4
LT - Lituania 4
PE - Perù 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
JM - Giamaica 3
KG - Kirghizistan 3
KZ - Kazakistan 3
MY - Malesia 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
UY - Uruguay 3
UZ - Uzbekistan 3
AO - Angola 2
AU - Australia 2
AW - Aruba 2
BO - Bolivia 2
EG - Egitto 2
GF - Guiana Francese 2
HR - Croazia 2
KE - Kenya 2
LB - Libano 2
MD - Moldavia 2
MN - Mongolia 2
NI - Nicaragua 2
RO - Romania 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
DM - Dominica 1
DZ - Algeria 1
GE - Georgia 1
GI - Gibilterra 1
GT - Guatemala 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LY - Libia 1
NO - Norvegia 1
PA - Panama 1
PR - Porto Rico 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
Totale 5.194
Salva come PNG Salva come JPEG
Città #
Singapore 371
Chandler 272
Ashburn 231
Rome 150
Beijing 82
Dublin 78
New York 74
Hefei 68
Hong Kong 65
Hyderabad 57
Ann Arbor 54
Jakarta 52
Los Angeles 52
Milan 50
Columbus 41
Ho Chi Minh City 41
Munich 41
San Mateo 40
Helsinki 35
The Dalles 35
Dallas 34
São Paulo 32
Wilmington 30
Boston 29
Frankfurt am Main 29
Hanoi 27
Jacksonville 27
Seoul 23
Moscow 22
Nanjing 22
Princeton 20
Cattolica 19
Kent 19
Marseille 18
Dearborn 17
London 15
Bari 14
Houston 14
Rio de Janeiro 14
Turku 14
Vienna 14
Boardman 13
Brooklyn 13
Brussels 13
Buffalo 13
Nuremberg 12
Atlanta 11
Bexley 11
Fairfield 11
Lawrence 11
Nürnberg 11
Phoenix 11
Santa Clara 11
Tokyo 11
Warsaw 11
Chicago 10
Seattle 10
Stockholm 10
Johannesburg 9
Lappeenranta 9
Leawood 9
Mexico City 9
Montreal 9
Toronto 9
Washington 9
Woodbridge 9
Brasília 8
North Bergen 8
Redwood City 8
Amsterdam 7
Bremen 7
Düsseldorf 7
Poplar 7
San Francisco 7
Vancouver 7
Abidjan 6
Council Bluffs 6
Denver 6
Lauterbourg 6
Newark 6
Orem 6
Querétaro 6
Quito 6
Roubaix 6
Turin 6
Andover 5
Augusta 5
Baghdad 5
Campinas 5
Fortaleza 5
Islington 5
Izmir 5
Madrid 5
Manchester 5
Mountain View 5
Naples 5
Salvador 5
Amman 4
Changsha 4
Detroit 4
Totale 2.805
Salva come PNG Salva come JPEG
Nome #
Patient-derived organoids and high grade serous ovarian cancer: from disease modeling to personalized medicine 174
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience. 163
A laparoscopic risk-adjusted model to predict major complications after primary debulking surgery in ovarian cancer: A single-institution assessment 153
Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 141
Privacy in Italian Clinical Reports: A NLP-Based Anonymization Approach 134
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience 132
Back to the future: The impact of oestrogen receptor profile in the era of molecular endometrial cancer classification 125
Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids 124
Building a personalized medicine infrastructure for gynecological oncology patients in a high-volume hospital 116
Targeting the hallmarks of ovarian cancer: The big picture 114
Infiltrating T lymphocytes and programmed cell death protein-1/programmed death-ligand 1 expression in endometriosis-associated ovarian cancer 111
Deep-Learning to Predict BRCA Mutation and Survival from Digital H&E Slides of Epithelial Ovarian Cancer 110
Pathologic response to neoadjuvant chemotherapy in advanced ovarian cancer: utility of a scoring system to predict outcomes 110
Epithelial ovarian cancer and brain metastases: might the BRCA status, PARP inhibitor administration, and surgical treatment impact the survival? 109
Impact of Comprehensive Genome Profiling on the Management of Advanced Non–Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program 108
One-Step Nucleic Acid Amplification (OSNA): A fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer 108
Robotic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II Study 106
Pd-l1 expression on circulating tumour-derived microvesicles as a complementary tool for stratification of high-grade serous ovarian cancer patients 103
Laparoscopic Management of a Small Bowel Recurrence of Endometrial Cancer 100
The immunohistochemical molecular risk classification in endometrial cancer: A pragmatic and high-reproducibility method 100
Integrating a Comprehensive Cancer Genome Profiling into Clinical Practice: A Blueprint in an Italian Referral Center 99
Assessment of preoperative nutritional status using BIA-derived phase angle (PhA) in patients with advanced ovarian cancer: Correlation with the extent of cytoreduction and complications 97
Emerging role of immune checkpoint inhibitors in the treatment of ovarian cancer 93
Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study 92
Secondary Laparoscopic Cytoreduction in Recurrent Ovarian Cancer: A Large, Single-Institution Experience 92
Recent progress in the use of pharmacotherapy for endometrial cancer 91
Laparoscopic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II Study 91
Integrating clinical-molecular data to predict PARP inhibitors efficacy in advanced ovarian cancer patients after interval cytoreductive surgery 90
Mesenteric lymph node involvement in advanced ovarian cancer patients undergoing rectosigmoid resection: Prognostic role and clinical considerations 90
Characterization of shared neoantigens landscape in Mismatch Repair Deficient Endometrial Cancer 89
Sentinel-node biopsy in apparent early stage ovarian cancer: final results of a prospective multicentre study (SELLY) 88
A cost-effectiveness analysis of an integrated clinical-radiogenomic screening program for the identification of BRCA 1/2 carriers (e-PROBE study 87
Oregovomab: an investigational agent for the treatment of advanced ovarian cancer 85
Advanced and recurrent endometrial cancer: State of the art and future perspectives 84
PARP Inhibitors Resistance: Mechanisms and Perspectives 83
Radiomics analysis of ultrasound images to discriminate between benign and malignant adnexal masses with solid morphology on ultrasound 83
Germline BRCA 1-2 status prediction through ovarian ultrasound images radiogenomics: a hypothesis generating study (PROBE study) 81
Systematic Review of Cytoreductive Surgery and Bevacizumab-Containing Chemotherapy in Advanced Ovarian Cancer: Focus on Safety 78
Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY) 75
Further refining 2020 ESGO/ESTRO/ESP molecular risk classes in patients with early-stage endometrial cancer: A propensity score–matched analysis 74
Robotic Splenectomy for Isolated Splenic Recurrence of Endometrial Adenocarcinoma 74
Laparotomy approach to sentinel lymph node detection in ovarian cancer using a near-infrared fluorescent system camera with indocyanine green dye 73
Correction: Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 73
Newly diagnosed ovarian cancer: Which first-line treatment? 72
Preclinical and Clinical Evidence of Lurbinectedin in Ovarian Cancer: Current Status and Future Perspectives 70
Are all mismatch repair deficient endometrial cancers created equal? A large, retrospective, tertiary center experience 69
Radiomics and Radiogenomics of Ovarian Cancer: Implications for Treatment Monitoring and Clinical Management 65
L1CAM Expression in Microcystic, Elongated, and Fragmented (MELF) Glands Predicts Lymph Node Involvement in Endometrial Carcinoma 64
Sentinel-node biopsy in early stage ovarian cancer: a prospective multicentre study (SELLY) 64
Minilaparoscopic Aortic Lymphadenectomy 61
Ovarian cancer patients with localized relapse: Clinical outcome and prognostic factors 60
Management of stage III and IVa uterine cancer 57
Laparoscopic Splenectomy for Secondary Cytoreduction in Ovarian Cancer Patients With Localized Spleen Recurrence: Feasibility and Technique 55
Verification of the prognostic precision of the new 2023 FIGO staging system in endometrial cancer patients - An international pooled analysis of three ESGO accredited centres 52
Timing and Pattern of Recurrence in Ovarian Cancer Patients with High Tumor Dissemination Treated with Primary Debulking Surgery Versus Neoadjuvant Chemotherapy 52
Mesenteric Lymph Node Involvement in Advanced Ovarian Cancer Patients Undergoing Rectosigmoid Resection: Prognostic Role and Clinical Considerations 50
Back to the future: The impact of oestrogen receptor profile in the era of molecular endometrial cancer classification 41
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group 25
Circulating tumor DNA in endometrial cancer: clinical significance and implications 13
Image-guided real-time optical biopsy in oncologic surgery: a systematic review of the role of confocal microscopy in the era of digital surgery 12
Circulating tumor DNA as a biomarker for predicting progression-free survival and overall survival in patients with epithelial ovarian cancer: a systematic review and meta-analysis 9
Totale 5.294
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.519
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.519
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202182 0 0 0 0 0 8 9 5 14 10 29 7
2021/2022312 12 13 4 24 18 5 15 55 15 27 49 75
2022/2023737 93 96 52 115 37 91 34 53 74 16 32 44
2023/2024523 12 116 23 47 26 57 43 33 5 30 65 66
2024/20251.350 39 28 96 60 91 63 63 50 153 168 311 228
2025/20261.855 391 225 224 420 562 33 0 0 0 0 0 0
Totale 5.294